Flunarizine and cinnarizine as vestibular depressants. A statistical study. 1978

P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva

The authors analysed the vestibular depressant activity of flunarizine and cinnarizine, as compared to a placebo, in 58 patients with peripheral labyrinthine disorders. The activity of the medications was judged by the reduction of the average velocity of the slow phase of the post-caloric nystagmus, before and after treatment. In spite of being administered in a smaller dosis, flunarizine appeared to have a more intense vestibular supressant activity, as judged by different statistical tests.

UI MeSH Term Description Entries
D007759 Labyrinth Diseases Pathological processes of the inner ear (LABYRINTH) which contains the essential apparatus of hearing (COCHLEA) and balance (SEMICIRCULAR CANALS). Inner Ear Disease,Ear Disease, Inner,Ear Diseases, Inner,Inner Ear Diseases,Labyrinth Disease
D010879 Piperazines Compounds that are derived from PIPERAZINE.
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D002150 Caloric Tests Elicitation of a rotatory nystagmus by stimulating the semicircular canals with water or air which is above or below body temperature. In warm caloric stimulation a rotatory nystagmus is developed toward the side of the stimulated ear; in cold, away from the stimulated side. Absence of nystagmus indicates the labyrinth is not functioning. Barany Test,Barany's Test,Baranys Test,Caloric Test,Test, Barany,Test, Barany's,Test, Caloric,Tests, Caloric
D004341 Drug Evaluation Any process by which toxicity, metabolism, absorption, elimination, preferred route of administration, safe dosage range, etc., for a drug or group of drugs is determined through clinical assessment in humans or veterinary animals. Evaluation Studies, Drug,Drug Evaluation Studies,Drug Evaluation Study,Drug Evaluations,Evaluation Study, Drug,Evaluation, Drug,Evaluations, Drug,Studies, Drug Evaluation,Study, Drug Evaluation
D005133 Eye Movements Voluntary or reflex-controlled movements of the eye. Eye Movement,Movement, Eye,Movements, Eye
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D014722 Vestibule, Labyrinth An oval, bony chamber of the inner ear, part of the bony labyrinth. It is continuous with bony COCHLEA anteriorly, and SEMICIRCULAR CANALS posteriorly. The vestibule contains two communicating sacs (utricle and saccule) of the balancing apparatus. The oval window on its lateral wall is occupied by the base of the STAPES of the MIDDLE EAR. Vestibular Apparatus,Ear Vestibule,Vestibular Labyrinth,Vestibule of Ear,Vestibulum Auris,Apparatus, Vestibular,Ear Vestibules,Labyrinth Vestibule,Labyrinth Vestibules,Labyrinth, Vestibular,Labyrinths, Vestibular,Vestibular Labyrinths,Vestibule, Ear,Vestibules, Ear,Vestibules, Labyrinth

Related Publications

P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
January 1974, ORL; journal for oto-rhino-laryngology and its related specialties,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
May 1987, Neurology,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
March 2020, Cephalalgia : an international journal of headache,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
December 1988, British journal of cancer,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
October 1994, Clinical neuropharmacology,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
January 1997, Movement disorders : official journal of the Movement Disorder Society,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
March 2017, European journal of clinical pharmacology,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
June 2004, Parkinsonism & related disorders,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
January 1977, VASA. Zeitschrift fur Gefasskrankheiten,
P L Mangabeira-Albernaz, and M M Ganança, and N F Novo, and E R de Paiva
January 2014, Journal of Parkinson's disease,
Copied contents to your clipboard!